These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 12504069)
1. Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Tandon R; Jibson MD Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():9-26. PubMed ID: 12504069 [TBL] [Abstract][Full Text] [Related]
2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
4. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ; Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663 [TBL] [Abstract][Full Text] [Related]
5. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
6. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
7. Aripiprazole versus other atypical antipsychotics for schizophrenia. Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570 [TBL] [Abstract][Full Text] [Related]
8. New generation antipsychotics for first episode schizophrenia. Rummel C; Hamann J; Kissling W; Leucht S Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012 [TBL] [Abstract][Full Text] [Related]
9. Selection of atypical antipsychotics for the management of schizophrenia. Sprague DA; Loewen PS; Raymond CB Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771 [TBL] [Abstract][Full Text] [Related]
11. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Smith RC; Leucht S; Davis JM Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237 [TBL] [Abstract][Full Text] [Related]
12. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Lerner V; Libov I; Kotler M; Strous RD Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862 [TBL] [Abstract][Full Text] [Related]
13. Treatment refractory schizophrenia: how should we proceed? Sharif ZA Psychiatr Q; 1998; 69(4):263-81. PubMed ID: 9793107 [TBL] [Abstract][Full Text] [Related]
14. Newer atypical antipsychotic medication versus clozapine for schizophrenia. Tuunainen A; Wahlbeck K; Gilbody SM Cochrane Database Syst Rev; 2000; (2):CD000966. PubMed ID: 10796559 [TBL] [Abstract][Full Text] [Related]
15. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
16. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S; Agoston T; Tamás T; Zoltán J Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [TBL] [Abstract][Full Text] [Related]
17. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023 [TBL] [Abstract][Full Text] [Related]
18. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
20. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]